Functional outcome after autologous blood injection for tennis elbow

Authors

  • Shivakumar G. V. Department of of Orthopaedics, Shivamogga Institute of Medical Sciences, Shimoga, Karnataka, India
  • Krishna Kumar M. S. Department of Orthopaedics, Vydehi Institute of Medical Sciences and Research centre, Nallurahalli, Near BMTC 18th Depot, Whitefield, Bangalore, India
  • Naveen P. R. Department of of Orthopaedics, Shivamogga Institute of Medical Sciences, Shimoga, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20164006

Keywords:

Tennis elbow, Injection, Blood

Abstract

Background: Tennis elbow is one of most common conditions found in athletes involved in upper limb sports. It has been reported that local injection of autologous blood in tennis elbow offers significant benefit by providing the necessary cellular and humoral mediators to induce a healing cascade. The objective of this study was to assess the efficacy of autologous blood injection in the treatment of tennis elbow.

Methods: 30 consecutive patients involved in upper limb sports and suffering from tennis elbow for more than 3 months duration not responsive to oral medication or other non-invasive treatment were given local injection of 2 ml autologous blood. Patients were assessed using the visual analogue scale (VAS) for pain and Nirschl scores before giving injection and at 1, 4, 8 and 12 weeks also at 6 and 9 months, repeat injection was given at 8 weeks if pain persisted.

Results: After Autologous blood injection (ABI) at 4 weeks there is significant (P <0.001) decrease in VAS pain score and Nirschl score. Though VAS pain score and Nirschl stage continued to improve after 8 weeks, but statistically not significant.

Conclusions: Autologous blood injection significantly improved clinical function and pain scores in patients with chronic tennis elbow who had previously undergone unsuccessful non-invasive treatment.

 

Author Biographies

Shivakumar G. V., Department of of Orthopaedics, Shivamogga Institute of Medical Sciences, Shimoga, Karnataka, India

Junior Resident, Dept. of Orthopaedics

Krishna Kumar M. S., Department of Orthopaedics, Vydehi Institute of Medical Sciences and Research centre, Nallurahalli, Near BMTC 18th Depot, Whitefield, Bangalore, India

Asst. Professor, Dept. of Orthopaedics

Naveen P. R., Department of of Orthopaedics, Shivamogga Institute of Medical Sciences, Shimoga, Karnataka, India

Asst. Professor, Dept. of Orthopaedics

References

Assendelft WJ, Hay EM, Adshead R, Bouter LM. Corticosteroid injections for lateral epicondylitis: a systematic review. Br J Gen Prac. 1996;46:209–16.

Haker E, Lunberg T. Pulsed ultrasound treatment in lateral epicondylalgia. Scand J Rehabil Med. 1991;23:115–8.

Gruchow HW, Pelletier D. An epidemiologic study of tennis elbow. Incidence, recurrence, and effectiveness of prevention strategies. Am J Sports Med. 1979;7:234–8.

Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164:1065–74.

Faro F, Wolf JM. Lateral epicondylitis: review and current concepts. J Hand Surg. 2007;32:1271–9.

Blackwell JR, Cole KJ. Wrist kinematics differs in expert and novice tennis players performing the backhand stroke: implications for tennis elbow. J Biomech. 1994;27:509–16.

Altan L, Kanat E. Conservative treatment of lateral epicondylitis: comparison of two different orthotic devices. Clin Rheumatol. 2008;27(8):1015-9

Jafarian FS, Demneh ES, Tyson SF. The immediate effect of orthotic management on grip strength of patients with lateral epicondylosis. J Orthop Sports Phys Ther. 2009;39(6):484-9.

Muto T, Kokubu T, Mifune Y. Temporary inductions of matrix metalloprotease-3 (MMP-3) expression and cell apoptosis are associated with tendon degeneration or rupture after corticosteroid injection. J Orthop Res. 2014;32(10):1297-304.

Osborne H. Stop injecting corticosteroid into patients with tennis elbow, they are much more likely to get better by themselves! J Sci Med Sport. 2010;13(4):380-1.

Paavola M, Kannus P, Jarvinen TA, Järvinen TL, Józsa L, Järvinen M. Treatment of tendon disorders: is there a role for corticosteroid injection? Foot Ankle Clin. 2002;7(3):501-3.

Edwards SG, Calandruccio JH. Autologous blood injections for refractory lateral epicondylitis. J Hand Surg Am. 2003;28:272–8.

Nirschl RP. Elbow tendinosis/tennis elbow. Clin Sports Med. 1992;11:851–70.

Regan W, Wold LE, Coonrad R, Morrey BF. Microscopic histopathology of chronic refractory lateral epicondylitis. Am J Sports Med. 1992;20(6):746-9.

DeSmedt T, de Jong A, Van-Leemput W, Lieven D, Van-Glabbeek F. Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment. Br J Sports Med. 2007;41:816–9.

Baily RA, Brock BH. Hydrocortisone in tennis elbow; a controlled series. Proc R Soc Med. 1957;50:389–90.

Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R, Bouter LM. Corticosteroid injections for lateral epicondylitis: a systematic review. Pain. 2002;96:23–40.

Kapetanos G. The effect of the local corticosteroids on the healing and biomechanical properties of the partially injured tendon. Clin Orthop Relat Res. 1982;163:170-9.

Taylor MA, Norman TL, Clovis NB, Blaha JD. The response of rabbit patellar tendons after autologous blood injection. Med Sci Sports Exerc. 2002;34(1):70-3.

Arik HO, Kose O, Guler F, Deniz G, Egerci OF, Ucar M. Injection of autologous blood versus corticosteroid for lateral epicondylitis: a randomised controlled study. J Ortho Surg. 2014;22(3):333-7.

Downloads

Published

2016-11-19

Issue

Section

Original Research Articles